Cipla reported INR14.03B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Arca Biopharma USD -25.07M 5.23M Mar/2025
aTyr Pharma USD -54K 25.9M Mar/2026
Bio Path USD -3.21M 631K Mar/2025
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Cipla INR 14.03B 4.48B Jun/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Immunic USD -22.78M 753K Jun/2024
Minerva Neurosciences USD -4.36M 1.71M Sep/2024
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
TherapeuticsMD USD -1.64M 700K Sep/2023
UPL INR 14.5B 21.08B Jun/2026